SCHEMBL6746016

SCHEMBL6746016

NS(=O)(=O)c1c(F)cc(-c2ncccc2-c2cccc(Cl)c2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORB Q92753 1/20 0.43
FEN1 P39748 1/20 0.41
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
PTGS1 P23219 2/20 0.40
PTGS2 P35354 2/20 0.40
CA1 P00915 5/20 0.39
CA2 P00918 5/20 0.39
PDE4A P27815 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
NFE2L2 Q16236 2/20 0.39
SCN9A Q15858 1/20 0.38
GLO1 Q04760 1/20 0.38
KMO O15229 1/20 0.38
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
MAOB P27338 1/20 0.37
KCNA5 P22460 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6749480 0.90 CA1 (0.40) FEN1PTGS1PTGS2CA1CA2
SCHEMBL6744241 0.88 FEN1 (0.43) FEN1PTGS1PTGS2CA1CA2
SCHEMBL6747444 0.88 PTGS2 (0.44) FEN1PTGS1PTGS2CA1CA2
SCHEMBL6746754 0.87 FEN1 (0.44) FEN1PTGS1PTGS2CA1CA2
SCHEMBL6743148 0.86 PTGS2 (0.51) FEN1HTTPTGS1PTGS2CA1
SCHEMBL6722740 0.86 NPC1 (0.44) RORBFEN1NPC1HPGDHTT
SCHEMBL6750081 0.85 PTGS1 (0.45) FEN1PTGS1PTGS2CA1CA2
SCHEMBL6743007 0.85 FEN1 (0.41) FEN1NPC1PTGS1PTGS2CA1
SCHEMBL6747351 0.85 FEN1 (0.41) FEN1PTGS1PTGS2CA1CA2
SCHEMBL6746734 0.83 LMNA (0.44) RORBFEN1CA1CA2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US claimed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US disclosed